decisionhealth Newsletters, Answer Books - 2006 Issue 3 (March)
Program_Memos / 2000 / AB-00-115
Subscribe or sign in to view the full article.
Article Overview
This article is a Medicare program memorandum from HCFA/DHHS for intermediaries and carriers. It explains a temporary update to pricing guidance for drugs and biologicals, including the status of previously issued instructions, effective and implementation timing, and administrative handling details. The memo is relevant to healthcare reimbursement staff, billing professionals, and anyone tracking Medicare payment policy updates.
Why This Topic Matters
It documents an interim Medicare pricing policy change affecting how payment allowances for drugs and biologicals are handled, which is important for reimbursement operations and policy compliance.
What You Will Learn
- The subject matter and policy area addressed by the memorandum.
- How the memorandum relates to prior program guidance.
- The timing and administrative status of the update.
- Who the memorandum is intended to inform within Medicare administration.
Who Should Read This
- Medicare intermediaries
- Medicare carriers
- Billing and reimbursement staff
- Healthcare compliance professionals
- Coding and payment policy analysts
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com